Expression and biological relationship of vascular endothelial growth factor-A and matrix metalloproteinase-9 in gastric carcinoma

Journal of International Medical Research

Volumn 39, Issue 6, 2011, Pages 2076-2085

  Yang, S ^a   Zhao, Z ^a   Wu, R ^a   Lu, H ^a   Zhang, X ^a   Huan, C ^a   Wang, C ^a   Wu, X ^a   Guan, G ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Gastric carcinoma; Immunohistochemistry; Matrix metalloproteinase 9; Prognosis; Stomach neoplasms; Vascular endothellial growth factor A

Indexed keywords

GELATINASE B; TUMOR MARKER; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; SURVIVAL RATE; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 84555208745     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900603     Document Type: Article

References (31)

1. Takayama S, Wakasugi T, Funahashi H, et al: Strategies for gastric cancer in the modern era. World J Gastrointest Oncol 2010; 2: 335-341.
2. Shigeoka H, Imamoto H, Nishimura Y, et al: Completeresponsetopreoperative chemoradiotherapy in highly advanced gastric adenocarcinoma. World J Gastrointest Oncol 2010; 2: 282-286.
3. Zhang D, Fan D: Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Rev Anticancer Ther 2007; 7: 1369-1378.
4. Afridi SP, Bano F, Shafiq-ur-Rahman: Pattern and presentation of carcinoma stomach. J Coll Physicians Surg Pak 2011; 21: 161-163.
5. Rak J, Milsom C, Yu J: Vascular determinants of cancer stem cell dormancy-do age and coagulation system play a role? APMIS 2008 116: 660-676.
6. Sato Y: Anti-angiogenic drugs. Nippon Rinsho 2010; 68: 1825-1829 [in Japanese, English abstract].
7. Groblewska M, Mroczko B, Szmitkowski M: The role of selected matrix metalloproteinases and theirinhibitors in colorectal cancer development. Postepy Hig Med Dosw (Online) 2010; 64: 22-30 [in Polish, English abstract].
8. Tuder RM, Yun JH: Vascular endothelial growth factor of the lung: friend or foe. Curr Opin Pharmacol 2008; 8: 255-260.
9. Mroczko B, Łukaszewicz-Zajac M, Guzinska-Ustymowicz K, et al: Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in gastric cancer. Folia Histochem Cytobiol 2009; 47: 491-496.
10. Borchard F: Classification of gastric carcinoma. Hepatogastroenterology 1990; 37: 223-232.
11. von Rahden BH, Feith M, Stein HJ: Carcinoma of the cardia: classification as esophageal or gastric cancer? Int J Colorectal Dis 2005; 20: 89-93.
12. Kase S, Osaki M, Honjo S, et al: Expression of cyclo-oxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas. Virchows Arch 2003; 442: 129-135.
13. Kallakury BV, Karikehalli S, Haholu A, et al: Increased expression of matrix metalloproteinases2 and9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 2001; 7: 3113-3119.
14. Vidal O, Metges JP, Elizalde I, et al: High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer. Br J Surg 2009; 96: 1443-1451.
15. Cabuk D, Basaran G, Celikel C, et al: Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early- stage gastric tumors: relationship with pathological factors and prognostic impact on survival. Oncology 2007; 72: 111-117.
16. Sier CF, Kubben FJ, Ganesh S, et al: Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996; 74: 413-417.
17. Kabashima A, Maehara Y, Kakeji Y, et al: Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res 2000; 6: 3581-3584.
18. Zheng H, Takahashi H, Murai Y, et al: Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 2006; 26: 3579-3583.
19. Yang Q, Ye ZY, Zhang JX, et al: Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. Anat Rec (Hoboken) 2010; 293: 2012-2019.
20. Bergers G, Brekken R, McMahon G, et al: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-744.
21. Lubbe WJ, Zhou ZY, Fu W, et al: Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer. Clin Cancer Res 2006; 12: 1876-1882.
22. Shou Y, Hirano T, Gong Y, et al: Influence of angiogeneticfactorsandmatrix metalloproteinases upon tumour progression in non-small-cell lung cancer. Br J Cancer 2001; 85: 1706-1712.
23. Zucker S, Mirza H, Conner CE, et al: Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998; 75: 780-786.
24. Riedel F, Götte K, Schwalb J, et al: Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol 2000; 17: 1099-1105.
25. Deryugina EI, Soroceanu L, Strongin AY: Up- regulation of vascular endothelial growth factorby membrane-type1matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 2002; 62: 580-588.
26. Ray A, Bal BS, Ray BK: Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: evidence for functional cooperation between serum amyloid A- activating factor-1 and AP-1. J Immunol 2005; 175: 4039-4048.
27. Büchler P, Reber HA, Büchler M, et al: Hypoxia- inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 2003; 26: 56-64.
28. Määttä M, Soini Y, Liakka A, et al: Differential expression of matrix metalloproteinase (MMP)- 2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin Cancer Res 2000; 6: 2726-2734.
29. Yano T, Tanikawa S, Fujie T, et al: Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer. Eur J Cancer 2000; 36: 601-609.
30. Iwasaki J, Nihira S: Anti-angiogenic therapy against gastrointestinal tract cancers. Jpn J Clin Oncol 2009; 39: 543-551.
31. Yang Q, Ye ZY, Zhang JX, et al: Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. Anat Rec (Hoboken) 2010; 293: 2012-2019.